BHVN Q2 2020 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M

Gross Profit

$7M68.5% margin

Operating Income

-$161M-1655.9% margin

Net Income

-$181M-1865.7% margin

EPS (Diluted)

$-3.08

QoQ Revenue Growth

+742.6%

Balance Sheet

Total Assets

$424M

Total Liabilities

$460M

Stockholders' Equity

-$35M

Cash & Equivalents

$261M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$0	—
Gross Profit	$7M	$0	—
Operating Income	-$161M	-$199M	+19.4%
Net Income	-$181M	-$211M	+14.3%